Detailed information for compound 2112921

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 422.268 | Formula: C25H34N4O2
  • H donors: 2 H acceptors: 3 LogP: 5.2 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cccc(c1)c1cn2c3c1cnc(n3)NCCCCCCCC(CCCC2)O
  • InChi: InChI=1S/C25H34N4O2/c1-31-21-13-9-10-19(16-21)23-18-29-15-8-6-12-20(30)11-5-3-2-4-7-14-26-25-27-17-22(23)24(29)28-25/h9-10,13,16-18,20,30H,2-8,11-12,14-15H2,1H3,(H,26,27,28)
  • InChiKey: LZPFBEBTZBKKFB-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens fms-related tyrosine kinase 3 References
Homo sapiens AXL receptor tyrosine kinase References
Homo sapiens MER proto-oncogene, tyrosine kinase References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma japonicum IPR008957,Fibronectin, type III-like fold,domain-containing Get druggable targets OG5_132328 All targets in OG5_132328
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus multilocularis neuroglian 0.003 0.5575 0.5575
Echinococcus granulosus twitchin 0.003 0.5575 0.5575
Schistosoma mansoni Neurotrimin precursor (hNT) 0.003 0.5575 0.5575
Loa Loa (eye worm) hypothetical protein 0.0034 0.6829 0.3956
Echinococcus granulosus Immunoglobulin 0.003 0.5575 0.5575
Loa Loa (eye worm) TK/KIN16 protein kinase 0.0038 0.8344 0.8734
Loa Loa (eye worm) hypothetical protein 0.0039 0.8746 1
Brugia malayi Fibronectin type III domain containing protein 0.0039 0.8746 1
Loa Loa (eye worm) hypothetical protein 0.0039 0.8746 1
Echinococcus multilocularis roundabout 2 0.0043 1 1
Echinococcus granulosus neuroglian 0.003 0.5575 0.5575
Schistosoma mansoni defective proboscis extension response (dpr)-related 0.003 0.5575 0.5575
Echinococcus granulosus neurotracting:lsamp:neurotrimin:obcam 0.0034 0.6829 0.6829
Loa Loa (eye worm) hypothetical protein 0.0034 0.6829 0.3956
Echinococcus granulosus defective proboscis extension response 0.003 0.5575 0.5575
Echinococcus multilocularis basement membrane specific heparan sulfate 0.003 0.5575 0.5575
Brugia malayi hypothetical protein 0.0039 0.8746 1
Schistosoma mansoni vesicular amine transporter 0.003 0.5575 0.5575
Brugia malayi Immunoglobulin I-set domain containing protein 0.0039 0.8746 1
Schistosoma mansoni nephrin 0.0039 0.8746 0.8746
Schistosoma mansoni cell adhesion molecule 0.0043 1 1
Echinococcus multilocularis Immunoglobulin 0.003 0.5575 0.5575
Loa Loa (eye worm) hypothetical protein 0.0034 0.6829 0.3956
Loa Loa (eye worm) hypothetical protein 0.0039 0.8746 1
Echinococcus multilocularis Immunoglobulin 0.003 0.5575 0.5575

Activities

Activity type Activity value Assay description Source Reference
EC50 (binding) > 1000 nM Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA LITERATURE. 27994735
IC50 (binding) = 160 nM Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay LITERATURE. 27994735
IC50 (binding) = 470 nM Inhibition of Flt3 (unknown origin) by microfluidic capillary electrophoresis assay LITERATURE. 27994735
IC50 (binding) = 920 nM Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay LITERATURE. 27994735

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.